Pharma Tech Outlook: Pharma Tech Magazine

The MT Group: A Yardstick of Quality in Translational Research

Top 10 CROs - 2021


As we enter 2021, it is no secret that the contract research organization (CRO) sector is witnessing rapid growth. The rising demand is primarily driven by the outsourcing practices of pharma organizations and the increasing capabilities of CROs. Factors like complex drug candidates and cost reductions are also playing a role in CRO growth. To keep up with such evolving trends in the sector, CROs are also shoring up their capabilities by incorporating robust technologies.

The integration of technologies like precision medicine, sensors, 3D bioprinting, and micro-sampling are enabling CROs to eliminate the need for animal testing in clinical studies. CROs that are on the helm of digitalization are unlocking the benefits or reduced costs and risks associated with clinical trials, while achieving unprecedented levels of efficiency and productivity.

Big data analytics is also turning out to be a vantage point for CROs to meet the evolving requirements of the pharmaceutical sector. Whether it compiling data from various sources or generating detailed reports, data analytics is becoming a go to technology for CROs. In addition, it is enabling CROs to draw crucial insights from vast troves of data and avoid the common risks during clinical trials.

With such innovations boosting accuracy and efficiency, the pharmaceutical sector is standing at the cusp of the next digital transformation. In order to assist CROs in shoring up their capabilities with robust technologies and effective solutions and services, we have compiled this issue of Pharma Tech Outlook. In this edition, we have listed top 10 Emerging CROs and top 10 CROs to highlight the ones that can help you escalate your chances of success. Equipped with innovative technological capabilities, these enlisted CRO solution providers and service companies are transforming the CRO landscape at the cloverleaf of various disruptive technologies. Besides, the magazine comprises insights from subject-matter experts and CXOs in the pharmaceutical sector on the latest industry trends, best practices, recent innovations, and highlights their expertise. We hope this issue of Pharma Tech Outlook helps you build the partnership you and your organization need to foster an environment driven by robust and efficient technology.

We present to you Pharma Tech Outlook’s “Top 10 CROs - 2021.”

    Top CROs

  • Microbiologics is the foremost biological products and services provider, focused on protecting the health and safety of people around the world. For 50 years, they have been partnering with healthcare and life science laboratories, manufacturers and suppliers across the globe to co-create and provide biological control materials, assay services and consulting for microbiology, molecular diagnostics and virology. Headquartered in Saint Cloud, Minnesota, the company has additional facilities in Michigan, Kentucky and California. Microbiologics has advanced industry standards for biological controls by adopting the most rigorous testing and quality standards including ISO 13485, ISO/IEC 17025, and ISO 17034. The company has an extensive distribution network spanning over 150 countries. For more information, visit Microbiologics, Inc

  • Wake Research’s unique network of 18 sites across the country and relationships in Europe orchestrates a variety of studies among a wide range of therapeutic areas and a diverse pool of patients in dermatology, women’s health, neurology, gastroenterology, and psychiatry, among other medical specialty areas. Having conducted thousands of clinical trials since 1984, Wake Research maintains its own proprietary patient database of over two million patients across all ages, ethnicities and demographics. The company provides its clients appropriate access to its patient population across Phase I-IV clinical trials in a variety of indications, including the ability to focus on minority populations when needed. Wake has been and remains committed to patient diversity in all their trials. Wake Research is known for performing on large vaccine trials as well as specialty population Phase I studies (e.g. Parkinson’s, Alzheimer’s, Crohn’s and Colitis) with its brand new pharmacy and state-of-the-art confinement unit

  • Clinilabs


    Clinilabs Drug Development Corporation is a contract research organization (CRO) that provides clinical drug development services to industry. We are experts in CNS drug development. Clinilabs provides first-in-human through end of phase 3 services, with a global core laboratory. It is an alternative to large CROs providing a full spectrum of offerings to meet the needs of our customers world wide. Since 2001, Clinilabs has completed more than 600 clinical trials, and has worked for 15 of the top 20 pharma companies in the world, to contribute to 14 successful new drug applications (NDAs)

  • Clinipace


    At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. Our personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach

  • Frontage Laboratories

    Frontage Laboratories

    Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the United States, China and other countries



    Helping medical device Sponsors improve healthcare since 1967, NAMSA is the only 100% medical device-focused, full continuum Contract Research Organization (CRO). Driven by our global regulatory expertise and in-depth therapeutic knowledge, NAMSA is dedicated to accelerating medical device product development, offering only the most proven solutions to move clients’ products through the development lifecycle efficiently and cost-effectively. From medical device testing; regulatory, reimbursement and quality consulting; and clinical research services, we are the industry’s premier, trusted partner for successful development and commercialization outcomes

  • Parexel


    Parexel is focused on the development of innovative new therapies to improve the world’s health. We do this by providing a suite of groundbreaking biopharmaceutical development services that help customers across the globe transform scientific discoveries into new treatments for patients. From clinical trial design to regulatory and consulting services to commercial and market access, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do

  • PPD


    PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 26,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development to deliver life-changing therapies that improve health

  • PRA Health Sciences

    PRA Health Sciences

    PRA Health Sciences is a full service global contract research organization providing a broad range of product development and data solution services to pharmaceutical and biotechnology companies around the world. Our global operations span more than 90 offices across North America, Europe, Asia, Latin America, South Africa, Australia, and the Middle East. PRA’s 19,000+ employees have participated in more than 3,800 clinical trials and have supported pivotal trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 85 products since 2000

  • Syneos Health

    Syneos Health

    Syneos Health is a fully integrated end-to-end clinical and commercial solution organization. We are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. Our business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies